Related Experiment Videos
Colony-stimulating factors as promoters of ameboid microglia
1Department of Neurology, Baylor College of Medicine, Houston, Texas 77030.
Abstract:
Immunomodulators were tested for their ability to stimulate proliferation and biologic activity of ameboid microglia. Only the colony-stimulating factors (CSFs), multipotential-CSF (multi-CSF) and granulocyte/macrophage-CSF (GM-CSF), were potent mitogens for microglia. Other immunomodulators, including interleukin-1, interleukin-2, interferon gamma, tumor necrosis factor, or granulocyte-CSF (G-CSF), had no effect upon microglial growth in vitro. Multi-CSF or GM-CSF were also observed to induce more rapid phagocytosis of polystyrene microspheres by cultured ameboid cells. In order to determine which immunomodulators alter brain inflammatory responses in vivo, we infused recombinant forms of GM-CSF, multi-CSF, macrophage-CSF, or G-CSF into the cerebral cortex of rats. Within 48 hr after infusion multi-CSF or GM-CSF stimulated the appearance of large numbers of mononuclear phagocytes at the site of injection. These same factors also accelerated the clearance of polystyrene microspheres from the brain. Our observations indicate that certain classes of immunomodulators which are mitogens and activators of ameboid microglia in vitro amplify the inflammatory response of the CNS in vivo by action upon intrinsic brain mononuclear phagocytes.
Insights
Colony-stimulating factors (CSFs) like multi-CSF and GM-CSF stimulate microglia growth and activity. These immunomodulators also enhance brain inflammatory responses in vivo, impacting central nervous system (CNS) inflammation.
Area of Science:
- Neuroimmunology
- Cell Biology
Background:
- Microglia are the primary immune cells of the central nervous system (CNS).
- Microglia play a crucial role in brain inflammation and immune responses.
- Understanding microglia activation is key to modulating CNS inflammatory conditions.
Purpose of the Study:
- To investigate the effects of various immunomodulators on ameboid microglia proliferation and activity.
- To determine which immunomodulators can stimulate microglial responses in vitro and in vivo.
- To assess the impact of specific colony-stimulating factors (CSFs) on brain inflammatory processes.
Main Methods:
- Culturing ameboid microglia in vitro and exposing them to different immunomodulators.
- Assessing microglial proliferation and phagocytic activity using polystyrene microspheres.
- Infusing recombinant CSFs (GM-CSF, multi-CSF, macrophage-CSF, G-CSF) into the rat cerebral cortex.
- Analyzing the inflammatory response and cell recruitment in vivo.
Main Results:
- Multipotential-CSF (multi-CSF) and granulocyte/macrophage-CSF (GM-CSF) were identified as potent mitogens for microglia in vitro.
- Other tested immunomodulators, including interleukins and TNF, did not affect microglial growth.
- Multi-CSF and GM-CSF accelerated phagocytosis of microspheres by cultured microglia.
- In vivo, multi-CSF and GM-CSF stimulated mononuclear phagocyte accumulation and accelerated microsphere clearance in the rat brain.
Conclusions:
- Certain immunomodulators, specifically multi-CSF and GM-CSF, act as potent activators of microglia.
- These CSFs amplify CNS inflammatory responses by acting on intrinsic brain mononuclear phagocytes.
- The findings highlight the role of specific CSFs in modulating neuroinflammation.